Sun, Aug 25 5:19am

Compare ADMS

Adamas Pharmaceuticals Inc [ADMS]
$6.06 0.07 (1.14%)

ADMS Profile

Sector Health Care
Industry Drug Manufacturers
Market Cap 170 Million
ADMS Description

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.

Visit Website

ADMS Earnings

EPS -0.90 P/E Ratio 0.00
Previous Earnings Thu, May 9, 2019
Latest Earnings Thu, Aug 8, 2019 (17 days ago) +0.83%

ADMS Dividend

Yield --
Ex-Date --
Pay Date --
History --

ADMS Charts

1 Year
Jun 11, 2019
Aug 31, 2018

Symbol Price Day % YTD %
ADMS $6.06 -1.14% -33.19%

Symbol Surfing

How can we make Symbol Surfing better?

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy